MONSOON COURIER BEACONPresident (Rayiys) Mustapha al-Makhtoum
3M CONTROVERSY AT MEABier Qassem, May 14, 4855: After a cabinet meeting today, President Mustapha al-Makhtoum indicated today that the main topic of discussion was yet another controversy over 3M, this time one being voiced in the Majatran Economic Association (MEA). His remarks included:
The proposal ostensibly against 3M by Federace Deltarska included four specific items. Two, to form a Majatran based pharmaceutical distributor and identifying health enhancing projects for advancement, are certainly things we can support and we would perhaps vainly hope that the other members of MEA would see the opportunity here and join the discussion and planning.
We have suggested instead of nations investing in the company, the 3M model, that the MEA itself be the initial owner maybe opening up to private investment when launched.
As far as health projects, obesity and lack of body tone in urban mobile device anchored children would be a timely project as would animal transmitted diseases since as land development occurs parasites, saprophytes, bacteria, viruses and such existing in harmony with animals in the wild will find new hosts as habitat disappears. Frankly, we would encourage this to be a joint venture of MEA, MEA pharmaceutical, MEA member health institutions and 3M. That would be our Plan A.
The other two proposals are restrictions on 3M. Let me say Jumhuriat al-Badara does support the concept of the MEA acting for Majatra to regulate trade with Majatra. No sooner did Badara decide to expand oil production than foreign powers and business interests started saying sell us your oil and gas reserves. Collective action can protect us from exploitation.
But how will a quota on sales by 3M affect us. Not much. Why? Our arrangement from the Free Radical days is that we pay a monthly fee for the right to buy any product at a discount. At the time the government wanted access to any drug useful in an epidemic we might not have independently developed. This was a safeguard. At that time the government paid for all prescription drugs and so bringing in 3M pharmacies to buy from seemed an unnecessary expense. Now the government only pays for drugs for those with low income but the system remains the same.
Accordingly we do not expect a quota would limit us with maybe three or four nations having the partnership arrangement with 3M which mean all those 3M pharmacies are buying much more quantitively than we are since our pharmacies are buying from our local producers and 3M through the Ministry of Health and Social Services.
The system works pretty good. Many common drugs are readily made locally. Quantitatively, there are four areas 3M does most of the business. There is so little profit in thyroid medicine that quality control has been a problem so everyone buys from 3M. The side effects for statins is so varied that having the huge array of known statins available from 3M to choose from limits ill side effects in practice. Advertising has created a market for psoriasis alleviation. We have not yet developed anything of any consequence so 3M is only reasonable source. Then there is antibiotics. Lots of side effects for lots of people. For those who need a much wider array to avoid nausea and debilitating drowsiness or liver damage, 3M is the choice.
We thus think more nations having our type of arrangement would likely be beneficial and would regret seeing limitations on it.
As to price setting; of course prices should be reasonable and we favor MEA asserting its authority in that regard. However, our impression is there is very little in the way of excessively priced pharmaceuticals that 3M is selling to us and we pretty much expect that is the case generally.
Jumhuriat al-Badara would really like to see the nations of Majatra take these proposals and work together to make a great leap forward in our continental health.
We are aware to get there we may have to get past deep resentments and many nations being otherwise engaged. So it goes.